46.46.Z - Wholesale of pharmaceutical goods
10.89.Z - Manufacture of other food products not elsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
30.92.Z - Manufacture of bicycles and invalid carriages
32.50.Z - Manufacture of medical and dental instruments and supplies
45.11.Z - Sale of cars and light motor vehicles
46.45.Z - Wholesale of perfume and cosmetics
47.73.Z - Dispensing chemist in specialised stores
49.41.Z - Freight transport by road
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 132,2 | 123,5 | 153,5 | 24,2 |
Liabilities and provisions | 41,8 | 64,1 | 68,9 | 7,5 |
Equity | 23,5 | 23,2 | 28,3 | 22,1 |
Total assets | 65,3 | 87,3 | 97,2 | 11,4 |
Cash and cash equivalents | 2,1 | 0,1 | 0,2 | 218,3 |
Depreciation | 3,4 | 3,5 | 4,8 | 37,5 |
Gross profit / loss | 12,3 | 3,5 | 9 | 159,1 |
EBITDA | 16,7 | 9,4 | 19,4 | 106,1 |
Net profit / loss | 10 | 3 | 6,6 | 118,9 |
Operating profit (EBIT) | 13,4 | 5,9 | 14,6 | 146,2 |
Current assets | 49,6 | 61,4 | 64,2 | 4,5 |
% | % | % | p.p. | |
Return on equity (ROE) | 42,7 | 13,1 | 23,4 | 10,3 |
Return on sales (ROS) | 7,6 | 2,5 | 4,3 | 1,8 |
Equity ratio | 36 | 26,6 | 29,1 | 2,5 |
EBITDA margin | 12,7 | 7,6 | 12,6 | 5 |
Gross profit margin | 9,3 | 2,8 | 5,8 | 3 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 87 | 151 | 128 | -23 |
Current ratio | 0,1 | |||
Net debt to EBITDA | 0,9 | 3,8 | 1,9 | -1,9 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.